Medtronic (NYSE:MDT) today released results from feasibility studies of its new “extravascular” EV-ICD System implantable cardioverter defibrillator designed with leads placed outside the hearts and veins, under the rib cage. The Fridley, Minn.-based medical giant touted results from the studies, which it said are the 1st to explore the novel extravascular placement, as showing the […]
Medtronic
Medtronic enters bundled ortho implant space with Responsive Orthopedics buy
Medtronic (NYSE:MDT) said this week that it acquired Responsive Orthopedics for an undisclosed amount, in preparation for its entry into the bundled hip-and-knee market. Minneapolis-based Responsive sells its total knee replacement implants to hospitals participating in federal bundling programs that reimburse based on outcomes rather than procedures performed. The company is also developing a hip implant […]
Study shows no increased cancer risk with Medtronic’s InFuse
A study of nearly 17,000 patients who had spine fusion procedures showed no increased cancer risk with the InFuse bone-growth protein made by Medtronic (NYSE:MDT). The retrospective cohort study, published online last week in the journal Spine, used data from the Washington State Comprehensive Hospital Abstract Reporting System, the Washington State Cancer Registry and death certificates from […]
Medtronic expects rev from surgical bot system by FY2019
On Monday, Medical device giant Medtronic (NYSE:MDT) unveiled plans that would see income from a robotic surgery unit by 2019, an entry into the orthopedic hip and knee replacement market in 2017 and an application for FDA regulatory clearance for a hybrid closed-loop insulin pump this summer. The company revealed these plans and outlined its […]
Appeals court again upholds NuVasive in patent win over Medtronic
A federal appeals court today again upheld its decision to award a win to NuVasive Inc. (NSDQ:NUVA) in 1 of its long-running patent infringement battles with spine implant rival Medtronic (NYSE:MDT). The U.S. Supreme Court in January remanded the case back to the U.S. Court of Appeals for the Federal Circuit, after deciding last year that a defendant’s belief regarding patent validity […]
Medtronic recalls Midas Rex sagittal saws on leaky seals risk
Medtronic (NYSE:MDT) said in late May it initiated a voluntary field action to recall its Midas Rex Sagittal Saws over issues with potential leakage of fluid into the motor through the units Rocker Housing Seal. Midas Rex Sagittal Saws are designed to be used with its Integrated Power Console system for the cutting, removal and […]
Medtronic reorganizes its restorative therapies segment
Medtronic (NYSE:MDT) is shuffling the deck at its restorative therapies group as it looks to boost its ailing spine and neuromodulation businesses. Fridley, Minn.-based Medtronic said yesterday that restorative therapies sales were up just 1% to $1.88 billion, including a -1% decline for its spine division at $737 million and a -5% slide to $494 million in neuromodulation. […]
Medtronic opens APac HQ, service & repair center in Singapore
Medtronic (NYSE:MDT) said today it opened a new Asia Pacific regional headquarters, which includes a service and repair center, in Singapore. The Fridley, Minn.-based company said that along with the opening it inked a deal with SingHealth to develop a “Centre of Excellence” for treating diabetes across Southeast Asia. “The opening of Medtronic regional headquarters in […]
Medtronic’s Q4, 2016 numbers top Wall Street
Medtronic (NYSE:MDT) today reported fiscal year-end results that topped both sales and earnings estimates on Wall Street, sending share prices up a tick this morning. The world’s largest pure-play medical device maker said it swung to Q4 black for the 3 months ended April 29, after putting up a -$1 million loss during the same […]
FDA slaps Class 1 label on Medtronic Capnostream battery pack recall
The FDA today labeled Medtronic‘s (NYSE:MDT) voluntary recall of battery packs used with its Covidien Oridion labeled Capnostream 20 and 20p patient monitors as Class I. The devices are being recalled due to a defect causing an increased risk of thermal damage in the packs. Class I recall designations, the agency’s most serious classification of […]
Medtronic, Qualcomm ink collaborative diabetes treatment deal
Medtronic (NYSE:MDT) said today that it inked a collaborative deal with Qualcomm (NASDAQ: QCOM) subsidiary Qualcomm Life to develop next-gen continuous glucose monitoring systems. The companies will initially focus on single-use CGM system designed for physicians who manage type 2 diabetes patients, Fridley, Minn.-based Medtronic said. “We believe that glucose should be a vital sign of […]